Company news
CytomX Therapeutics, Inc. news in 2019
CytomX Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
CytomX Therapeutics Provides Updates on Lead Clinical Programs and 2020 Portfolio Outlook
December 18, 2019
CytomX Therapeutics to Present at Upcoming Healthcare Conferences
November 10, 2019
CytomX Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update
November 6, 2019
CytomX Therapeutics Announces Initiation of Phase 2 Clinical Trial Evaluating the Anti-PD-L1 Probody CX-072 in Combination with YERVOY® in Patients with Relapsed or Refractory Melanoma
October 28, 2019
CytomX Therapeutics to Announce Third Quarter 2019 Financial Results
October 23, 2019
CytomX Therapeutics Announces Appointment of Amy C. Peterson, M.D. as Chief Development Officer
October 13, 2019